Author Archive: BIOtechNOW Editor

Open Communication Helps Reduce Rare Disease Drug Development Risk

115x76allisonMparks

One of the most important keys to successful relationships – be it in life or rare disease drug development – is open, honest and frequent communication, according to a panel of rare disease experts speaking at the Therapeutic Workshop: “Balancing the Rick-Reward in Rare Disease Drug Development” at the BIO CEO & Investor Conference in New York on Monday. Without engaging the key groups at the right time and the right manner, companies entering this Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , ,

Cancer Insurance Checklist: Guía de Cobertura Médica para Personas con Cáncer

20070112

As the world marks World Cancer Day and the U.S. continues to implement the Affordable Care Act, the Cancer Support Community (CSC) is pleased to announce the launch of a Spanish language version of the successful resource, the Cancer Insurance Checklist. This easy-to-use guide is available to assist people with cancer, a history of cancer or at risk for cancer choose a health insurance plan. The need is great.  Nearly a third (31.1 percent) of Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

FDA Check-Up: Drug Development and Manufacturing Challenges

Paul Hastings

I have over 27 years of experience in the biotechnology and pharmaceutical industry. My current company, OncoMed Pharmaceuticals, is working at the cutting edge of oncology research, focused on antibodies that target a specific set of cells within tumors, known as tumor initiating cells, that drive the growth of the tumor and can differentiate into various cell types within the tumor. Currently, we have five products in clinical development in over 13 completed or ongoing Read More >

Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

The Arrival of Actionable Personalized Medicine

kevin-davies115-76

The pace of implementation of next-generation sequencing (NGS) in a clinical context, which almost rivals the development of the technology over the past decade, is driving the cost of a full genome sequence down to just a few thousand dollars. Diagnostic companies and medical centers are now routinely offering comprehensive genome analysis, as evidenced by the recent report from Baylor College of Medicine in the New England Journal of Medicine on the first 250 patients Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

New Cancer Treatments Seek to Give the Immune System Superpowers

Wendy Selig 2013

Melanoma is scary. It is aggressive, spreads quickly to far-away organs with the stealth and cunning of the most adept villain, and it is increasingly striking young people-it is now the most common form of cancer diagnosed in women 25-29. But the “good guys” are fighting back with increasing success. As the CEO of the Melanoma Research Alliance (MRA), a patient-focused, science-based organization dedicated to fighting this deadly skin cancer, I see signs every day Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , ,